Literature DB >> 24015751

Calcific mitral stenosis in the hemodialysis patient.

Adrian Sequeira1, Liam Morris, Brijesh Patel, Lucas Duvall, Deepa Gali, Denisse Menendez, Guy Alexander.   

Abstract

The dialysis patient is prone to elevations in the calcium phosphorus product and hyperparathyroidism, which contributes to valvular and vascular calcification. We present the case of a young lady on chronic dialysis that developed mitral calcification complicated by severe mitral stenosis, caseous calcification and retinal embolization. She subsequently required mitral valve replacement.
© 2013 International Society for Hemodialysis.

Entities:  

Keywords:  Mitral; annulus; calcification; caseous; embolus

Mesh:

Year:  2013        PMID: 24015751     DOI: 10.1111/hdi.12094

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  4 in total

Review 1.  Mitral Annular Calcification: Association with Atherosclerosis and Clinical Implications.

Authors:  Luiz Rafael P Cavalcanti; Michel Pompeu B O Sá; Álvaro M Perazzo; Antonio C Escorel Neto; Rafael A F Gomes; Alexander Weymann; Konstantin Zhigalov; Arjang Ruhparwar; Ricardo C Lima
Journal:  Curr Atheroscler Rep       Date:  2020-02-07       Impact factor: 5.113

2.  Caseous calcification of the mitral annulus: computed tomography features.

Authors:  Fernanda Boldrini Assunção; Diogo Costa Leandro de Oliveira; Alair Augusto Sarmet Moreira Damas Dos Santos; Marcelo Souto Nacif
Journal:  Radiol Bras       Date:  2016 Jul-Aug

3.  Risk of Cerebral Embolization with Caseous Calcification of the Mitral Annulus: Review Article.

Authors:  Charles A Dietl; Christopher M Hawthorn; Veena Raizada
Journal:  Open Cardiovasc Med J       Date:  2016-11-15

4.  The Crosstalk between Calcium Ions and Aldosterone Contributes to Inflammation, Apoptosis, and Calcification of VSMC via the AIF-1/NF-κB Pathway in Uremia.

Authors:  Jianbing Hao; Jie Tang; Lei Zhang; Xin Li; Lirong Hao
Journal:  Oxid Med Cell Longev       Date:  2020-12-04       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.